Published in Mol Endocrinol on May 01, 1992
LINE-1 RNA splicing and influences on mammalian gene expression. Nucleic Acids Res (2006) 1.94
RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res (1996) 1.71
RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol Cell Biol (1994) 1.66
Identification and characterization of novel human tissue-specific RFX transcription factors. BMC Evol Biol (2008) 1.62
Identification of an isoform of the estrogen receptor messenger RNA lacking exon four and present in the brain. Proc Natl Acad Sci U S A (1993) 1.15
Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary. Proc Natl Acad Sci U S A (1995) 1.05
Triple primer polymerase chain reaction. A new way to quantify truncated mRNA expression. Am J Pathol (1996) 0.91
Regulatory factor X4 variant 3: a transcription factor involved in brain development and disease. J Neurosci Res (2007) 0.87
Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer. Am J Pathol (1997) 0.85
Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance. Br J Cancer (1997) 0.82
Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues. Breast Cancer Res (2000) 0.80
Hypothesis: Artifacts, Including Spurious Chimeric RNAs with a Short Homologous Sequence, Caused by Consecutive Reverse Transcriptions and Endogenous Random Primers. J Cancer (2015) 0.80
Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases. Br J Cancer (1999) 0.78
Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol (1999) 1.56
Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res (1998) 1.46
The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res (1999) 1.37
Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res (1985) 1.37
Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry (1990) 1.37
Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol (1987) 1.36
Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab (1997) 1.34
Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. Cancer Res (1999) 1.34
Expression of lumican in human breast carcinoma. Cancer Res (1998) 1.33
Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res (1999) 1.32
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res (1996) 1.31
Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer (2006) 1.29
High-affinity anti-oestrogen binding site distinct from the oestrogen receptor. Nature (1980) 1.29
Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res (1999) 1.23
Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol (2000) 1.21
Psoriasin (S100A7). Int J Biochem Cell Biol (1998) 1.20
Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol (2003) 1.17
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. J Natl Cancer Inst (1984) 1.14
Inhibition of transcription selectively reduces the level of ubiquitinated histone H2B in chromatin. Biochem Biophys Res Commun (1994) 1.04
Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Cancer Res (1983) 1.02
Estrogen receptor-beta mRNA variants in human and murine tissues. Mol Cell Endocrinol (1998) 1.02
Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis (1992) 0.99
Mechanisms of oestrogen antagonism by nonsteroidal antioestrogens. Mol Cell Endocrinol (1982) 0.99
Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst (1996) 0.99
Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res (1984) 0.96
Microsomal binding sites for nonsteroidal anti-estrogens in MCF 7 human mammary carcinoma cells. Demonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene. J Biol Chem (1984) 0.96
Measurement of the relative binding affinity of zearalenone, alpha-zearalenol and beta-zearalenol for uterine and oviduct estrogen receptors in swine, rats and chickens: an indicator of estrogenic potencies. Comp Biochem Physiol C (1989) 0.94
Role of wild-type estrogen receptor-beta in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells. Am J Physiol Endocrinol Metab (2008) 0.94
Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. Histopathology (2008) 0.93
Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol (1999) 0.93
Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res (1986) 0.90
The binding of tamoxifen to human mammary carcinoma cytosol. Eur J Cancer (1980) 0.88
Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site. J Clin Endocrinol Metab (1983) 0.88
Identification of differentially expressed genes using minute amounts of RNA. Biotechniques (1996) 0.87
Biological actions of prolactin in human breast cancer. Recent Prog Horm Res (1987) 0.87
Estrogen induction of N-myc and c-myc proto-oncogene expression in the rat uterus. Endocrinology (1987) 0.87
Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res (1998) 0.87
Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Cell Growth Differ (1990) 0.87
Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Cancer Res (1984) 0.87
Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells. J Biol Chem (1998) 0.86
A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion. Breast Cancer Res Treat (1997) 0.85
Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer. Am J Pathol (1997) 0.85
Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res (1990) 0.85
A high-affinity binding site for the antioestrogens, tamoxifen and CI 628, in immature rat uterine cytosol which is distinct from the oestrogen receptor. J Endocrinol (1981) 0.85
Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers. Cancer Res (2000) 0.85
Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells. J Cell Biochem (1996) 0.84
Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro. Endocrinology (1985) 0.84
Resveratrol reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes. Int J Cardiol (2008) 0.83
Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene. J Cell Biochem (1996) 0.83
Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res (1996) 0.83
The knee-chest position does not improve the efficacy of ipecac-induced emesis. Am J Emerg Med (1989) 0.83
Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts. J Steroid Biochem Mol Biol (1994) 0.82
Functional characteristics of a novel murine estrogen receptor-beta isoform, estrogen receptor-beta 2. J Mol Endocrinol (2000) 0.81
Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res (1987) 0.81
Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. J Clin Endocrinol Metab (1986) 0.80
C-myc gene chromatin of estrogen receptor positive and negative breast cancer cells. Mol Cell Endocrinol (1993) 0.80
Differential effects of phorbol esters on proliferation and calcyclin expression in human endometrial carcinoma cells. Cell Growth Differ (1992) 0.80
Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues. Breast Cancer Res (2000) 0.80
Phorbol esters differentially regulate the expression of insulin-like growth factor-binding proteins in endometrial carcinoma cells. Endocrinology (1992) 0.80
Estrogen receptor diminishes DNA-binding activities of chicken GATA-1 and CACCC-binding proteins. DNA Cell Biol (1997) 0.79
Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins. Cancer Res (1991) 0.79
Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue. Biochem Biophys Res Commun (1996) 0.79
Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells. J Steroid Biochem Mol Biol (1991) 0.79
Effects of transforming growth factors and regulation of their mRNA levels in two human endometrial adenocarcinoma cell lines. J Steroid Biochem Mol Biol (1992) 0.78
Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases. Br J Cancer (1999) 0.78
Establishment of a gastric epithelial progenitor cell line from a transgenic mouse expressing the simian virus 40 large T antigen gene in the parietal cell lineage. Cell Prolif (2008) 0.78
Estrogen receptor beta: mine is longer than yours? J Clin Endocrinol Metab (1998) 0.78
Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues. Br J Cancer (1999) 0.78
Modifications in the aminoether side chain of clomiphene influence affinity for a specific antiestrogen binding site in MCF 7 cells cytosol. Biochem Biophys Res Commun (1981) 0.78
Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Cancer Res (1992) 0.78
Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens. Breast Cancer Res Treat (1994) 0.78
Influence of estrogen receptor variants on the determination of ER status in human breast cancer. Breast Cancer Res Treat (1999) 0.78
Growth factors in normal and malignant uterine tissue. Ann N Y Acad Sci (1991) 0.78
Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells. J Mol Endocrinol (1999) 0.77
Regulation of c-jun and jun-B by progestins in T-47D human breast cancer cells. Mol Endocrinol (1992) 0.77
Estrogen receptor-alpha mRNA variants in murine and human tissues. Mol Cell Endocrinol (1999) 0.76
Nongenomic activation of the GC-A enzyme by resveratrol and estradiol downstream from membrane estrogen receptors in human coronary arterial cells. Nutr Metab Cardiovasc Dis (2006) 0.76
Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol (1992) 0.76
Actions of pituitary prolactin and insulin-like growth factor II in human breast cancer. Cancer Treat Res (1988) 0.75
25-Hydroxycholecalciferol receptors in human breast cancer. Br J Cancer (1979) 0.75
The path of screw insertion for stabilization of the scapholunate joint. A radiological study. J Hand Surg Eur Vol (2012) 0.75
The interaction of estrogen- and antiestrogen-receptor complexes with polynucleotides. Endocrinology (1983) 0.75
Uterine epithelial cells in primary culture: a model system to study cell proliferation. Cell Mol Biol (1990) 0.75
Effect of progesterone on protein synthesis and secretion by cultured epithelial cells from guinea-pig endometrium. Cell Tissue Res (1989) 0.75
Trisomy 5 in acute lymphoblastic leukaemia. Acta Paediatr (2003) 0.75
Effects of 17 beta-estradiol and growth factors on c-fos gene expression in endometrial epithelial cells in primary culture. Mol Cell Endocrinol (1990) 0.75
Mechanisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells. J Steroid Biochem Mol Biol (1992) 0.75
Mandatory health insurance coverage for cancer clinical trials. McGeorge Law Rev (2005) 0.75
Partial palatomaxillary core ostectomy with multiple flap reconstruction. Head Neck Surg (1986) 0.75
Specific effect of oestrone sulphate on protein synthesis and secretion by cultured epithelial cells from guinea-pig endometrium. J Endocrinol (1989) 0.75
Regulation of c-fos expression in primary culture of guinea pig glandular epithelial cells stimulated by growth factors and estradiol. Reprod Nutr Dev (1990) 0.75
The path of screw insertion for stabilization of the scapholunate joint: a cadaveric study. Hand Surg (2014) 0.75
Compared effects of oestrogens and oestrone sulphate on the epithelial cell surface of guinea-pig endometrium (in vivo and in vitro studies). Exp Clin Endocrinol (1987) 0.75
Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells. Mol Endocrinol (1993) 0.75
Regulation of gene expression in T-47D human breast cancer cells by progestins and antiprogestins. Hum Reprod (1994) 0.75
A role for the insulin-like growth factors as estromedins in the rat uterus. Trans Assoc Am Physicians (1987) 0.75